Organon & Co 2024 SR
The report highlights Organon's commitment to advancing women's health through innovation, access, and gender equity. The company achieved 100% pay equity in its 20 largest markets and reported that 47% of director-level and above roles are held by women. Environmental progress includes a 4.8% reduction in Scope 1 and 2 emissions and a 6% reduction in water usage compared to a 2020 baseline. Additionally, Organon has helped prevent approximately 76 million unintended pregnancies through its Her Promise Access Initiative.
Company: Organon & Co
Sector: Health Care
Country: United States
Year: 2024
Type: SR
Pages: 10
Organon & Co
ESG Highlights
The report highlights Organon's commitment to advancing women's health through innovation, access, and gender equity. The company achieved 100% pay equity in its 20 largest markets and reported that 47% of director-level and above roles are held by women. Environmental progress includes a 4.8% reduction in Scope 1 and 2 emissions and a 6% reduction in water usage compared to a 2020 baseline. Additionally, Organon has helped prevent approximately 76 million unintended pregnancies through its Her Promise Access Initiative.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management